← Open Payments lookup

ADELINE ABAM: Open Payments

NPI 1902277056 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,217 in 66 payments from 8 companies in 2025. Trend: 2023 $173 · 2024 $644 · 2025 $1,217

Food & beverage: $1,217
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$216
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$212
Janssen Pharmaceuticals, Inc5$179
Neurocrine BioSciences, Inc.5$162
Otsuka America Pharmaceutical, Inc.10$155
Alkermes, Inc.7$138
Luye Pharma (USA) Ltd.4$92
Teva Pharmaceuticals USA, Inc.3$64

Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, INGREZZA, REXULTI, ERZOFRI EXTENDED-RELEASE, ARISTADA, LYBALVI.

Industry payments across TX — which companies pay providers there.